TheraRadar
Company Portfolios →

Changchun GeneScience Pharmaceutical Co., Ltd.

37 active trials across 8 therapeutic areas

37
Active Trials
21
Phase 1
10
Phase 2
8
Phase 3
8
Therapeutic Areas

Oncology

14 active / 17 total
Solid Tumor (Advanced)
6 active
7 total since 2015
ALL
2 active
2 total since 2015
NSCLC
2 active 2 Ph3
2 total since 2015
Hepatocellular Carcinoma
1 active 1 Ph3
1 total since 2015
Breast Cancer
1 active 1 Ph3
1 total since 2015
SCLC
1 active 1 Ph3
1 total since 2015
Head and Neck Cancer
1 active 1 Ph3
1 total since 2015
Prostate Cancer
0 active
1 total since 2015
Non-Hodgkin Lymphoma
0 active
1 total since 2015

Immunology

8 active / 12 total
Rheumatoid Arthritis
6 active
6 total since 2015
Ankylosing Spondylitis
2 active
6 total since 2015

Cardiovascular

8 active / 8 total
Myocardial Infarction
5 active 3 Ph3
5 total since 2015
Atrial Fibrillation
3 active
3 total since 2015

Endocrine

5 active / 10 total
Growth Hormone Deficiency
4 active
9 total since 2015
Hyperthyroidism
1 active
1 total since 2015

Women's Health

1 active / 3 total
Endometriosis
1 active
1 total since 2015
Infertility
0 active
2 total since 2015

Musculoskeletal

0 active / 5 total
Gout
0 active
5 total since 2015

CNS

0 active / 1 total
Multiple Sclerosis
0 active
1 total since 2015

Urology

0 active / 1 total
Overactive Bladder
0 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)